What this means
Researchers compared 30 young men who were athletes, active, or inactive. Men with higher fitness tended to have higher levels of this blood marker.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- 30 healthy young males aged 18 to 25
- Kind of research
- A study
The science
- Original title
- Associations of Serum MOTS-c with Exercise Capacity and Antioxidant Markers in Young Males: A Cross-Sectional Study.
- Authors
- Zhang Z, Zhang X, Wang C et al.
- Journal
- Antioxidants (Basel, Switzerland)
- Published
- Oct 27, 2026
- Study type
- Study
- PMID
- 42939841 ↗
Abstract
Mitochondrial-derived peptide MOTS-c is an exercise-responsive mitokine, yet its associations with exercise capacity and antioxidant markers remain unclear. This cross-sectional study examined serum MOTS-c across three stratified groups of 30 healthy young males aged 18 to 25 years: elite track and field athletes (n = 10), recreationally active individuals (n = 10), and sedentary controls (n = 10). Measurements included serum MOTS-c, SOD, post-exercise MDA, VO2max, forced vital capacity, vertical jump height, handgrip strength, back muscle endurance, and post-fatigue back muscle force. Serum MOTS-c increased progressively across groups (athletes: 507.51 ± 67.42 pg/mL; active: 440.32 ± 32.83 pg/mL; sedentary: 319.31 ± 99.07 pg/mL; p < 0.001; Hedges' g = 2.13 for athlete vs. sedentary comparison). Serum MOTS-c was strongly correlated with absolute VO2max (r = 0.892), SOD (r = 0.847), post-exercise MDA (r = -0.910), back muscle endurance (r = 0.725), and post-fatigue back muscle force (r = 0.812) (all p < 0.001). In exploratory hierarchical regression, post-exercise MDA remained significantly associated with serum MOTS-c after adjustment for VO2max, whereas SOD was not independently associated. Handgrip strength showed no significant correlation with MOTS-c (r = 0.315, p = 0.090). These findings suggest that serum MOTS-c is associated with exercise capacity and circulating antioxidant markers in young males, although the cross-sectional design precludes causal inference.
Zhang Z, Zhang X, Wang C et al. Associations of Serum MOTS-c with Exercise Capacity and Antioxidant Markers in Young Males: A Cross-Sectional Study. Antioxidants (Basel, Switzerland). 2026. doi:10.3390/antiox15101267. PMID: 42939841. https://pubmed.ncbi.nlm.nih.gov/42939841/
Related research
AGEs-RAGE Axis and Mitochondrial-Derived Peptides in Advanced Chronic Kidney Disease: Interconnected Pathways Beyond Inflammation and Nutrition.
Background. Chronic kidney disease [CKD] is characterized by increased glycoxidative stress, inflammation, and mitochondrial dysfunction.
Emerging regulators of human physiology and disease; sORF-encoded microproteins.
The human genome contains hundreds of thousands of short open reading frames (sORFs), yet their translational products, hereafter referred to as sORF-encoded microproteins (also historically termed micropeptides), have…
Mitokines as bioenergetic stress signals in cardiovascular disease: mitochondrial communication, endocrine adaptation, and translational implications.
Cardiovascular disease is strongly influenced by mitochondrial dysfunction, yet how mitochondrial stress is communicated beyond the affected cell to coordinate systemic responses remains incompletely understood.
Mitochondrial-derived peptides in female reproduction: Emerging regulators of oocyte competence and novel therapeutic opportunities for infertility.
Female infertility affects approximately 17.5% of adults worldwide. Mitochondria are central to oocyte developmental competence, and a novel class of mitochondrial genome-encoded peptides, mitochondrial-derived…
Mitochondrial-derived peptides (MDPs) activated by physical exercise as therapeutic targets for metabolic disorders: A systematic review.
BACKGROUND: Type 2 diabetes mellitus and metabolic diseases are increasing worldwide and are closely linked to mitochondrial dysfunction.
Mots-c protects kidneys in diabetic mice by lowering LARS1
Researchers found MOTS-c helped protect kidneys in mice with diabetes, and in human kidney cells. This is early work, and it does not show that MOTS-c would help people.
